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1Background and Purpose—Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy 
(CADASIL) is the most common monogenic form of stroke usually presenting with migraine with aura, lacunar infarcts, 
and cognitive impairment. Acute encephalopathy is a less recognized presentation of the disease.
Methods—Data collected prospectively from 340 consecutively recruited symptomatic patients with diagnosis of CADASIL 
seen in a British National CADASIL clinic was retrospectively reviewed and original clinical records and imaging 
obtained. An encephalopathic event was defined as an acute event of an altered state of consciousness in a patient with 
CADASIL, manifesting with signs of brain dysfunction, which warranted hospital admission in the absence of any other 
cause. Clinical characteristics, risk factors, and outcome of encephalopathic presentations were studied.
Results—A total of 35 of 340 (10.3%) participants had a history of 50 encephalopathic events which was the first hospital 
presentation of CADASIL in 33 (94.3%) patients. Most commonly reported features during episodes were visual 
hallucinations (44%), seizures (22%), and focal neurological deficits (60%).Complete recovery within 3 months was 
reported in 48(96%) episodes. In 62% of episodes, there was a history of migraine or migraine aura directly preceding 
the encephalopathy. In 2 out of 15 cases where magnetic resonance imaging during episodes was available, unilateral 
focal cortical swelling was seen. A past history of migraine was independently associated with encephalopathy (odds 
ratio=12.3 [95% CI, 1.6–93.7]; P=0.015).
Conclusions—In up to 10% of CADASIL patients, a reversible encephalopathy is the first presentation leading to diagnosis. 
The strong association with migraine suggests a shared pathogenesis. Focal cortical swelling may be seen on magnetic 
resonance imaging during the acute episode.   (Stroke. 2019;50:00-00. DOI: 10.1161/STROKEAHA.118.023661.)
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Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the 
most common form of familial stroke. It results from a small 
vessel arteriopathy because of mutations in the NOTCH3 
gene.1 Typical features include migraine usually with aura, la-
cunar strokes, depression, and later in life vascular cognitive 
impairment and dementia.
A less common, but increasingly recognized clinical mani-
festation is acute encephalopathy,2,3 also referred to as CADASIL 
coma, which has been reported to be the first major presenting 
feature in some CADASIL patients.2 This presentation is not al-
ways clinically recognized with many patients having been misdi-
agnosed as having infective encephalitis and treated accordingly.
It has been suggested that encephalopathy may be related 
to migraine,4 but the clinical features, predisposing factors, 
and prognosis remain poorly described. Furthermore, the 
pathogenesis is still unknown, and whether the episodes result 
in any permanent sequelae is uncertain.
We describe the clinical features, risk factors, imaging 
appearances, and outcome of CADASIL encephalopathy 
in a large prospectively collected cohort of patients with 
CADASIL.
We defined an encephalopathic event as an acute event 
of altered state of consciousness in a patient with CADASIL, 
manifesting with signs of brain dysfunction, which warrants 
hospital admission in the absence of any other cause.
Methods
Data supporting the findings of this study is available from the corre-
sponding author on reasonable request.
Data on 340 CADASIL patients seen in British CADASIL 
National Referral Centre was collected over a 20-year period between 
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1996 and 2016.The referral center sees patients from all over Great 
Britain with a confirmed or suspected diagnosis of CADASIL.
All patients in the study had a confirmed diagnosis of 
CADASIL, with a recognized pathogenic NOTCH3 mutation, 
resulting in a change in a cysteine amino acid in one of the ep-
idermal growth factor repeat (EGFr) domain in the extracellular 
portion of the NOTCH3 protein. We included only patients who 
had experienced at least one symptom of the disease, and asymp-
tomatic individuals in whom CADASIL was detected on predictive 
testing were not included.
All patients were assessed by a consultant neurologist, and data 
were collected using a standardized questionnaire at first visit and fol-
low-up encounters. The proforma included questions on the presence 
and age of onset of all known manifestations of CADASIL, including 
encephalopathic events, as well as signs, and symptoms experienced 
during those events.
A previous report described 6 cases of encephalopathy in the first 
70 patients from the same cohort.2
Standard Protocol Approvals, Registrations, 
and Patient Consents
Data were collected with local Ethics Committee approval 
(REC 16/EE/0118), and all patients gave written informed 
consent.
For the purpose of our study, the data from the prospec-
tively collected database was then retrospectively reviewed, 
including demographics, data on cardiovascular risk factors 
and the type of NOTCH3 mutations.
In addition to data collected on the proforma, hospital 
records, and magnetic resonance imaging (MRI) scans per-
formed during encephalopathic episodes were reviewed.
A migraine was defined according to the International 
Classification of Headache Disorders 
(ICHD). The first edition (ICHD-1) was used from 1996 to 
2004, followed by ICHD-2 from 
2004 to 2013 and ICHD-3 (β version) from 2013 to 
2016.5 Stroke was defined clinically as a focal neurological 
episode lasting ≥24 hours because of a presumed vascular 
cause.
MRI scans performed during admission for encephalop-
athy were reviewed by a consultant neuroradiologist. We eval-
uated T1- and T2-weighted and diffusion-weighted images 
(DWIs). We also compared imaging abnormalities with those 
on follow-up or prevent MRI.
Statistical Analysis
We compared clinical features and risk factors between 
CADASIL patients who had and had not experienced en-
cephalopathy using 2 sample t test and Fisher exact tests as 
appropriate. Multiple logistic regression was then used to de-
termine whether encephalopathy was independently associ-
ated with any variables, using the presence of encephalopathy 
as the outcome and history of stroke, migraine, age, and sex 
as variables.
To determine whether specific NOTCH3 mutation sites 
were associated with encephalopathy, mutations were mapped 
on the NOTCH3 protein using C-Bioportal Mapper (http://
www.cbioportal.org/mutation_mapper.jsp).
Mutations were named according to human genome varia-
tion society nomenclature.6 We used the χ2 test to compare the 
frequency of mutation loci in the 2 groups, and the mutation 
position along the gene according to which of the 34 EGFr 
domains they are located in. Additionally, mutation location 
was grouped into EGFr 1 to 6 and EGFr 7 to 34, and the χ2 test 
was used to compare the groups.
Statistical analyses were performed using the R statistical 
software (version 3.2.2). Probability values of P<0.05 were 
considered statistically significant.
Results
Out of 340 CADASIL patients, 35 (10.3%) had experienced 
at least one encephalopathic event. In total, there were 50 
events with 13 patients experiencing >1 event. The average 
age of patients at the time of their first encephalopathic 
event was 42 years, ranging between 19 and 62 (SD=12.9; 
Figure 1). In 33 (94%) of all encephalopathy cases, it was 
the first major symptom that leads to hospital admission or 
resulted in specialist neurological referral which led to the 
investigations and diagnosis of CADASIL. Many of these 
patients had previously experienced migraine, but this had 
not led to a diagnosis of CADASIL. In 2 (5.7%) affected 
cases encephalopathy was the first ever symptom of the di-
sease. The most common diagnosis communicated to patients 
was meningitis or encephalitis, reported in 20 (40 %) of epi-
sodes. We know of 15 cases treated with antimicrobials. In 
addition, 2 cases were diagnosed as cerebral vasculitis of 
whom one was treated with steroids and azathioprine and one 
with steroids alone, with no improvement in symptoms noted. 
We were able to obtain lumbar puncture results for 14 epi-
sodes, although this is likely to be an underestimate of total 
number of lumbar punctures performed. In one case there 
was an isolated increase in cell count showing 11 cells/µl 
pleomorphic cells, with normal values of protein and glu-
cose. In all the remaining cases the results were reported as 
normal. We were able to obtain EEG reports recorded during 
5 encephalopathic episodes. This included 2 with clinical sei-
zures during the course of admission, which showed isolated 
abnormalities over left anterior temporal area in one case and 
slow activity in the left hemisphere in the other. In addition, 
3 episodes without seizures had EEGs; of these one had ab-
normal right temporal background activity, one bilateral slow 
waves especially in the left temporal lobe, and one had no 
specific changes.
Features of the Events
Features of the events and availability of the investigations are 
presented in Table I in the online-only Data Supplement.
Typically the encephalopathic episode began with mi-
grainous symptoms progressing without any break to a period 
of reduced consciousness during which patient would develop 
additional neurological signs.
A migraine or isolated migrainous aura immediately 
preceded 31 (62.0%) of the 50 episodes. In addition, some 
patients experienced nonmigraine type headache later during 
the episodes and, therefore, any type of headache was a fea-
ture in 36 (72.0%) of episodes.
Seizures were reported in 11 events (22.0%). These were 
described as generalized or tonic-clonic events (7 episodes), 
and complex partial seizures (2 episodes), unspecified seizure 
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type (2 episodes). None of these patients suffered from sei-
zures before the episode. In one case seizures recurred about 8 
months following the encephalopathic presentation.
Focal neurological signs during the events included uni-
lateral weakness (9 episodes 18.0%), unilateral sensory deficit 
(7 episodes 14.0%), dysarthria (6 episodes 12.0%), aphasia 
(11 episodes 22.0%), neglect or inattention (4 episodes 8.0%), 
apraxia (2 episodes 4.0%), visual agnosia (2 episodes 4.0%), 
and dyslexia (2 episodes 4.0%). In total, 30 (60%) events 
where accompanied by at least one of the above.
Out of the total 50 episodes, 22 (44.0%) were accom-
panied by visual hallucinations. Reports of hallucinations 
included absence of lower half of people’s body (metamor-
phopsia; 1 case), people, dead people or ghosts (5 cases), and 
animals (2 cases) as well as more complex hallucinations such 
as blood pressure machine turning to evil spirit or boyfriend 
on the ward with another woman. Paranoid delusions were 
reported in 2 (4.0%) episodes. As it was a criterion for diag-
nosis of an encephalopathic event, reduced consciousness was 
a feature in all patients ranging between confusion and coma.
The duration of longest hospital admission was avail-
able for 25 (71.4%) patients. It varied between 1 and 21 days 
with a mean duration of 9.7 days (SD=5.5). Encephalopathic 
episodes recurred in 13 of 35 subjects (37.1%) with 1, 2, 3, 
and 4 recurrent events occurring in 6, 3, and 4 individuals, 
respectively.
Complete patients’ recovery within 1 week was noted for 
12 (24%) episodes, within 2 weeks for 20 (40%), within 1 
month 37 (74 %), and within 3 months for 48 (96%).
Reported residual deficits after discharge included short-
lived (3 weeks) unilateral sensory disturbance (1 case) and 
cognitive decline (4 cases). Cognitive assessment, 1 week 
postevent for one case, revealed an impairment of spatial and 
visuoperceptual processing as well as executive dysfunction 
with normal verbal and abstraction skills (Mini-Mental State 
Examination of 27/30).This was followed by gradual recovery 
to baseline function. In the second case assessment about 2 
weeks after the event showed reduction in visual processing 
speed and working memory with normal verbal fluency (Mini-
Mental State Examination 26/30) again followed by gradual 
recovery to baseline. In 2 other cases, nonspecific worsening 
of cognitive symptoms was reported following the event with 
no subsequent recovery noted.
Risk Factors
Demographics, clinical, and cardiovascular risk factors were 
compared between CADASIL patients with and without a his-
tory of encephalopathy and are shown in the Table. The only 
factors that differed significantly on simple logistic regression 
were migraine as a first symptom, and history of migraine, 
which were more common in the encephalopathy group, and 
history of stroke, which was less common in the encephalop-
athy group.
To determine which risk factors were independent pre-
dictors of encephalopathy, multiple logistic regression was 
performed entering covariates found to be significantly as-
sociated with encephalopathy on simple logistic regression 
(history of migraine and history of stroke) as well as age and 
sex. On multiple logistic regression, history of migraine was 
independently associated with a history of an encephalopathic 
event (odds ratio, 12.3 [95% CI, 1.6–93.7]; P=0.015) and 
history of stroke was negatively associated with a history of 
encephalopathy (odds ratio, −0.41 [95% CI, −0.96 to −0.17]; 
P=0.04).
Relation to Genotype
The location of the NOTCH3 mutation was available for all 
patients. The distribution of mutations is shown in Figure 2. 
There was no apparent difference in the distribution between 
cases with and without encephalopathy.
There was no difference in the EGF repeat in which the 
mutation occurred between cases with and without enceph-
alopathy (χ2, P=0.388) and in the proportion who had a 
Figure 1. Histogram shows the percentage of patients in each age group during the first and all encephalopathic events.
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mutation in EGFR repeat 1 to 6 versus 7 to 34 (encephalop-
athy 33 v 2 versus nonencephalopathy 256 v 49, χ2 P=0.170).
The most common mutation sites were the same in both 
groups (p.Arg182Cys, p.Arg169Cys, and p.Arg141Cys) and 
there were no differences in the frequency of these muta-
tions between both groups (p.Arg182Cys, P value=0.11; 
p.Arg169Cys, P value=0.34; and p.Arg141Cys, P value=0.82).
Imaging
Brain MRI scans were available in all cases but MRIs per-
formed during an encephalopathic episode were available for 
review for 15 episodes. T1, T2-weighted, and FLAIR images 
were obtained for all 15 episodes and DWIs for 8 episodes. All 
scans were performed using 1.5 Tesla scanners in neurology 
or medical units of the local hospitals. Mean (SD) time be-
tween admission and MRI was 6.3 (SD=7.4) days, with time 
ranging between within 24 hours and 18 days.
All 15 cases had MRI showing signs of moderate to se-
vere cerebral small vessel disease. There were no focal re-
gions of impaired diffusion consistent with acute ischemia 
in any of the 8 cases with DWI available. In 2 patients, MRI 
revealed unilateral focally increased signal intensity with 
swelling and increased volume of the involved cortical gyri on 
T2-weighted images. In the first case, the lesions were located 
in the cortical gray matter and subcortical white matter of 
the right parietal, temporal and occipital gyri and during the 
second event affecting the same patient, 4 years later, in the 
left parietal, and left medial and lateral temporal gyri extend-
ing to left occipital lobe (Figure 3). DWI during the second 
event revealed subtle increased signal intensity in the periph-
eral cortical gray matter with corresponding hypodensity on 
apparent diffusion coefficient map. Follow-up images avail-
able 40 days after the first event revealed near complete reso-
lution of the findings (Figure 3). In the second patient, similar 
lesions were present in the left parietal, left lateral temporal, 
and occipital areas. The second patient had a generalized sei-
zure during the event. No seizure-like activity was reported 
in the first case.
Discussion
In this large cohort of CADASIL patients, encephalopathy 
occurred in ≈10% of individuals. Importantly, it was the first 
major symptom leading to specialized neurological or hospital 
presentation in over 90% of individuals with encephalopathy. 
In many cases, the diagnosis was delayed and alternative 
treatment given, particularly for infective encephalitis, which 
emphasizes the importance of awareness of this syndrome.
This study highlights the typical features of CADASIL 
encephalopathy. In contrast to the subcortical features of is-
chemic damage occurring in CADASIL with lacunar stroke 
syndromes, CADASIL encephalopathy was associated with a 
range of cortical symptoms and signs, including aphasia, ne-
glect and inattention, apraxia, visual agnosia. Although a rare 
feature of CADASIL outside of encephalopathic episodes, 
seizures were frequent during encephalopathic episodes and 
tended not to recur outside the acute illness. Visual hallucina-
tions were also a prominent feature occurring in almost 50% 
of encephalopathic episodes and paranoid delusions were oc-
casionally reported.
Encephalopathic episodes tended to be self-terminating 
and patients recovered within days to a few weeks without 
specific treatment. They did recur in more than one-third of 
Table. Characteristics of Patients Who Experienced Encephalopathy Compared With the Rest of the Cohort
 
Encephalopathy 
35 Cases
No Nonencephalopathy
305 Cases P Value
Age on assessment, mean (SD) years 46.3 (10.95) 48.0 (11.76) 0.3845
Sex (female/male) 18/17 180/125 0.4697
Hypertension, N (%) 12 (34.3) 62 (20.3) 0.0809
Smoking history, N (%) 16 (45.7) 172 (56.4)  0.2818
Diabetes mellitus, N (%) 2 (5.7) 15 (4.9) 0.6903
Migraine as first symptom, N (%) 31 (88.5)* 198 (64.9)* 0.0039*
History of migraine, N (%) 34 (97.1)* 221 (72.4)* 0.0007*
Age of first migraine, mean (SD), years 28.3 (12.4) 28.8 (13.2) 0.8418
History of migraine with aura, N (%) 34 (97.1)* 194 (63.6)* 1.256×10−05*
History of stroke, N (%) 8 (22.9)* 144 (47.2)* 0.0067*
Age of first stroke, mean (SD), years 44.5 (8.9) 46.9 (9.6) 0.4777
History of dementia, N (%) 1 (2.9) 30 (8.8) 0.2272
History of depression, N (%) 10 (28.6) 103 (33.6) 0.5765
Comparison of demographics, clinical, and cardiovascular risk factors between patients with and without a 
history of encephalopathy. Hypertension defined as on antihypertensive medications are blood pressure >140 
mm Hg systolic or >90 diastolic. Smoking defined as current or ex-smoker. History of dementia defined as (1) the 
dementia diagnosis is made by a hospital specialist or (2) cognitive impairment is severe enough to disrupt social 
and occupational functions or (3) Mini-Mental State Examination <23. Depression defined as a clinical diagnosis 
requiring treatment.
*Significant P values.
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the patients with 5 being the maximum number of episodes in 
an individual patient. Episodes were usually accompanied by 
full recovery (96% of cases) although there were rare reports 
of persisting cognitive symptoms; however, detailed long-
term assessment in these cases was not available.
The major risk factor for encephalopathy was migraine; 
we found a strong association between a past history of mi-
graine and risk of encephalopathy. Furthermore, in over 60% 
of encephalopathic episodes, there was a history of migraine 
immediately preceding the episode. This proportion is likely 
to be underestimated as some patients had poor recollection 
of the initial symptoms before the encephalopathy. This high 
prevalence of migraine as preceding symptom is consistent 
with previously reported case series.2,3
In some cases, drawing a distinction between confu-
sional migraine and encephalopathic episodes was difficult. 
Although unclassified by the ICHD-III-20135 confusional mi-
graine is also well described in sporadic migraine.7 We de-
fined an encephalopathic event as an acute event of an altered 
state of consciousness in a patient with CADASIL, manifest-
ing with signs of brain dysfunction, which warranted hospital 
admission in the absence of any other cause. We understand 
that hospital admission might seem an arbitrary inclusion 
considering that confusional migraine is not uncommon in 
CADASIL.8
Rare cases of migraine in patients without CADASIL 
have been associated with coma.9,10 Holub et al11 described 
a fatal case of migraine in a 12-year-old girl with a history 
of repeated loss of consciousness. Furthermore, a similar 
presentation referred to as coma or encephalopathy has been 
reported in several cases of familial hemiplegic migraine, an-
other genetic form of migraine.12,13
Apart from the association with migraine, the only other 
association we found was a weakly significant inverse associ-
ation between stroke and encephalopathy. This reflects a sim-
ilar inverse relationship between the history of migraine and 
stroke reported in the same cohort4 but needs replication in 
further populations.
There is little previous information available on brain 
imaging appearances during CADASIL encephalopathic 
episodes. DWI images in our study were available for the ma-
jority of patients but these were usually performed during the 
nonacute phase. DWI scans during the acute encephalopathic 
episode were only available for 8 cases.
In those patients who had DWI, there were no instances 
of acute ischemic lesions. In 2 patients, we found changes of 
cortical swelling and hyperintensity on T2-weighted imaging 
consistent with cerebral edema. Such findings have been re-
ported in status migrainosus and in both sporadic and familial 
hemiplegic migraine.14,15 Cerebral edema can also occur sec-
ondary to status epilepticus but only one of the 2 patients had 
seizures and these were not prolonged. Despite no overt signs 
of acute ischemia, in one of those cases, there were subtle dif-
fusion changes suggesting presence of mild cytotoxic edema. 
Similar changes have been previously observed in cases of fa-
milial hemiplegic migraine.16
The cause of encephalopathy in CADASIL remains uncer-
tain. The close association with migraine, and the evolution 
Figure 2. Distribution of mutations in the NOTCH3 protein among patients with history of encephalopathy (top) and without history of encephalopathy (bot-
tom). x axis: amino acids along the protein; including 34 epidermal growth factor repeat (EGFr) domains in the extracellular domain(marked); y axis: number 
of cases where each lollipop represents a different mutation site. Three most frequent mutations marked. Image created with C-bioportal. Mapper. (http://
www.cbioportal.org/mutation_mapper.jsp).
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Figure 3. Patient 1 during first episode. Flair images revealing increased signal and swelling in the right temporal and parietal regions (approximate area of 
changes marked) (A) with near complete resolution of changes on follow-up images 40 days later (B). Patient 1 during the second episode. T2 weighted and 
flair images (C) revealing cortical swelling and signal abnormalities in the left parietal and temporal region (marked area). Diffusion-weighted image (DWI) 
images are showing mild increase in signal with corresponding low signal on apparent diffusion coefficient map (D).
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of encephalopathic episodes from migraine, suggests shared 
pathophysiological mechanisms.
Cortical spreading depression (CSD) is characterized by 
appearance of depolarization waves spreading at a slow ve-
locity across the cortical surface which is a complex event 
that coincides with, and is caused by, a dramatic failure of 
brain ion homeostasis and efflux of excitatory amino acids 
from nerve cells.17 Reports on symptoms of migrainous aura 
explained by excitation-depression wave propagating across 
the human primary visual cortex at the same rate as CSD sug-
gest a possible link between the 2.18 Imaging of cerebral blood 
flow in patients during migraine attacks has shown reduced 
blood flow that propagated across the cortex at the same rate 
and with similar signs of vascular impairment as CSD.19 These 
studies provide indirect evidence to support the view that 
CSD could be an underlying mechanism for migrainous aura. 
Consistent with a possible role for CSD in migraine increased 
susceptibility to CSD has been shown in transgenic NOTCH3 
mice.20 The strong relation between encephalopathy and mi-
graine with aura that we have shown might be the result of a 
shared pathogenesis. The position of the mutation along the 
NOTCH3 gene has suggested as a determinant of the spectrum 
and severity of CADASIL disease,21 but we found no associ-
ation between the location of the mutation in the NOTCH3 
gene and encephalopathy risk. It is also possible that other 
genetic factors may influence risk, and it has been shown that 
modulating genes seem to influence the severity of white mat-
ter damage in patients with CADASIL22 although the respon-
sible genes have not been identified.
Our study does have some limitations. Although using a 
prospectively collected database, it was a retrospective study 
and in many cases, we were not able to obtain MRI images or 
cerebrospinal fluid results performed during admission. We do 
not have reliable data on consciousness level as events hap-
pened in multiple hospitals and we did not have access to nurs-
ing records or observation charts which would include this.
In many cases, we could not establish whether the focal 
neurological signs were part of an initial migraine with aura 
or developed later in the course of encephalopathic episode. 
Similarly, there is a clinical overlap between confusional mi-
graine and encephalopathic episodes described in CADASIL 
patients, and those 2 might represent different ends of the 
same spectrum.
Conclusions
Our results emphasize that encephalopathy is an important 
feature of CADASIL and may be the first major presenting 
symptom, and therefore, requires a high index of suspicion. 
The diagnosis of CADASIL encephalopathy should be con-
sidered in patients with a known diagnosis of CADASIL, or 
typical white matter changes present on neuroimaging, who 
present with a prolonged episode of confusion or loss of con-
sciousness, and who may also have seizures of cortical signs. 
Although its mechanism remains uncertain encephalopathy is 
closely associated with migraine with aura, and an increased 
propensity to spreading depression may play a role in the 
increased frequency of both migraine with aura and encepha-
lopathy seen in CADASIL.
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